Copyright
©The Author(s) 2023.
World J Clin Cases. Oct 6, 2023; 11(28): 6782-6791
Published online Oct 6, 2023. doi: 10.12998/wjcc.v11.i28.6782
Published online Oct 6, 2023. doi: 10.12998/wjcc.v11.i28.6782
Number of patients | Percentage (%) | |
Metastatic disease | ||
Metastatic during initial diagnosis | 17/61 | 27.9 |
Inferior vena cava/renal vein neoplastic thrombus | 14/61 | 23.0 |
Treatment | ||
Neoadjuvant chemotherapy | 10/53 | 18.9 |
Open adrenalectomy | 48/60 | 80.0 |
Extensive resection | 17/60 | 27.9 |
Laparoscopic resection | 4/60 | 6.6 |
Robotic resection | 1/60 | 1.6 |
Biopsy without resection | 7/60 | 11.7 |
Complete surgical resection | 42/47 | 89.4 |
Tumor confirmation testing | ||
Positive CD99 immunohistochemistry staining | 60/61 | 98.4 |
Positive molecular EWSR1-FLI1translocation | 27/27 patients | 100 |
Adjuvant therapy | Required in 32 patients | |
Chemotherapy | 20/32 | 62.5 |
Radiotherapy | 1/32 | 3.1 |
Chemoradiotherapy | 11/32 | 34.4 |
Outcomes | ||
Survival data | 42 patients | |
Median overall survival | 15 mo | |
24-mo overall survival | 17/42 | 40.5 |
Median disease-free survival | 10 mo | |
24-mo disease-free survival | 14/42 | 33.3 |
- Citation: Manatakis DK, Tsouknidas I, Mylonakis E, Tasis N, Antonopoulou MI, Acheimastos V, Mastoropoulou A, Korkolis DP. Primary adrenal Ewing sarcoma: A systematic review of the literature. World J Clin Cases 2023; 11(28): 6782-6791
- URL: https://www.wjgnet.com/2307-8960/full/v11/i28/6782.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v11.i28.6782